192 related articles for article (PubMed ID: 32405513)
1. βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for
Demirci S; Gudmundsdottir B; Li Q; Haro-Mora JJ; Nassehi T; Drysdale C; Yapundich M; Gamer J; Seifuddin F; Tisdale JF; Uchida N
Mol Ther Methods Clin Dev; 2020 Jun; 17():912-921. PubMed ID: 32405513
[TBL] [Abstract][Full Text] [Related]
2. Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease.
Ramadier S; Chalumeau A; Felix T; Othman N; Aknoun S; Casini A; Maule G; Masson C; De Cian A; Frati G; Brusson M; Concordet JP; Cavazzana M; Cereseto A; El Nemer W; Amendola M; Wattellier B; Meneghini V; Miccio A
Mol Ther; 2022 Jan; 30(1):145-163. PubMed ID: 34418541
[TBL] [Abstract][Full Text] [Related]
3. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
Urbinati F; Hargrove PW; Geiger S; Romero Z; Wherley J; Kaufman ML; Hollis RP; Chambers CB; Persons DA; Kohn DB; Wilber A
Exp Hematol; 2015 May; 43(5):346-351. PubMed ID: 25681747
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
[TBL] [Abstract][Full Text] [Related]
5. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease.
Poletti V; Urbinati F; Charrier S; Corre G; Hollis RP; Campo Fernandez B; Martin S; Rothe M; Schambach A; Kohn DB; Mavilio F
Mol Ther Methods Clin Dev; 2018 Dec; 11():167-179. PubMed ID: 30533448
[TBL] [Abstract][Full Text] [Related]
7. β-globin gene transfer to human bone marrow for sickle cell disease.
Romero Z; Urbinati F; Geiger S; Cooper AR; Wherley J; Kaufman ML; Hollis RP; de Assin RR; Senadheera S; Sahagian A; Jin X; Gellis A; Wang X; Gjertson D; Deoliveira S; Kempert P; Shupien S; Abdel-Azim H; Walters MC; Meiselman HJ; Wenby RB; Gruber T; Marder V; Coates TD; Kohn DB
J Clin Invest; 2013 Jul; 123(8):3317-30. PubMed ID: 23863630
[TBL] [Abstract][Full Text] [Related]
8. Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.
Brusson M; Chalumeau A; Martinucci P; Romano O; Felix T; Poletti V; Scaramuzza S; Ramadier S; Masson C; Ferrari G; Mavilio F; Cavazzana M; Amendola M; Miccio A
Mol Ther Nucleic Acids; 2023 Jun; 32():229-246. PubMed ID: 37090420
[TBL] [Abstract][Full Text] [Related]
9. A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice.
Wang X; McKillop WM; Dlugi TA; Faber ML; Alvarez-Argote J; Chambers CB; Wilber A; Medin JA
J Gene Med; 2024 Jan; 26(1):e3567. PubMed ID: 37455676
[TBL] [Abstract][Full Text] [Related]
10. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model.
Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ
PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
[TBL] [Abstract][Full Text] [Related]
12. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
[TBL] [Abstract][Full Text] [Related]
13. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM
J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
[TBL] [Abstract][Full Text] [Related]
15. Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
Zhu J; Li H; Aerbajinai W; Kumkhaek C; Pirooznia M; Saxena A; Dagur P; Chin K; Rodgers GP
Blood; 2022 Nov; 140(21):2276-2289. PubMed ID: 36399071
[TBL] [Abstract][Full Text] [Related]
16. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
17. RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells.
Uchida N; Washington KN; Mozer B; Platner C; Ballantine J; Skala LP; Raines L; Shvygin A; Hsieh MM; Mitchell LG; Tisdale JF
Hum Gene Ther Methods; 2017 Apr; 28(2):91-99. PubMed ID: 28267358
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Brendel C; Negre O; Rothe M; Guda S; Parsons G; Harris C; McGuinness M; Abriss D; Tsytsykova A; Klatt D; Bentler M; Pellin D; Christiansen L; Schambach A; Manis J; Trebeden-Negre H; Bonner M; Esrick E; Veres G; Armant M; Williams DA
Mol Ther Methods Clin Dev; 2020 Jun; 17():589-600. PubMed ID: 32300607
[TBL] [Abstract][Full Text] [Related]
19. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.
Imren S; Fabry ME; Westerman KA; Pawliuk R; Tang P; Rosten PM; Nagel RL; Leboulch P; Eaves CJ; Humphries RK
J Clin Invest; 2004 Oct; 114(7):953-62. PubMed ID: 15467834
[TBL] [Abstract][Full Text] [Related]
20. Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease.
Zhu J; Kren BT; Park CW; Bilgim R; Wong PY; Steer CJ
Biochemistry; 2007 Jun; 46(23):6844-58. PubMed ID: 17508724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
